Phase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab (Pembro) plus Carboplatin and Etoposide Chemotherapy (Chemo) or Chemo Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC)

Gonzalez-Billalabeitia, EnriqueVon Amsberg, GunhildArslan, CagatayMehra, NivenEmmenegger, UrbanRobbrecht, Debbie G. J.Yu, Evan Y.2026-03-272026-03-2720250732-183X1527-7755https://hdl.handle.net/20.500.14365/8866https://doi.org/10.1200/JCO.2025.43.16_suppl.5059eninfo:eu-repo/semantics/closedAccessPhase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab (Pembro) plus Carboplatin and Etoposide Chemotherapy (Chemo) or Chemo Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC)Conference Object10.1200/JCO.2025.43.16_suppl.5059